Application of a physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) model for prediction of drug-drug interactions (DDIs) involving the JAK1/2 inhibitor Ruxolitinib in Caucasians and Japanese

Author(s): Sibylle Neuhoff, Iain Gardner
Year:

Learn More LinkedIn Twitter Facebook Email